Metabolome of chronic fatigue syndrome

Por Roerink, Megan E., Bronkhorst, Ewald M., van der Meer, Jos W. M.
Publicado no Proc Natl Acad Sci U S A (2017)

Interleukin-1 as a mediator of fatigue in disease: a narrative review

Por Roerink, Megan E., van der Schaaf, Marieke E., Dinarello, Charles A., Knoop, Hans, van der Meer, Jos W. M.
Publicado no J Neuroinflammation (2017)

Central delivery of iodine-125–labeled cetuximab, etanercept and anakinra after perispinal injection in rats: possible implications for treating Alzheimer’s disease

Por Roerink, Megan E., Groen, Rob JM, Franssen, Gerben, Lemmers-van de Weem, Bianca, Boerman, Otto C., van der Meer, Jos WM
Publicado no Alzheimers Res Ther (2015)

Cytokine inhibition in chronic fatigue syndrome patients: study protocol for a randomized controlled trial

Por Roerink, Megan E., Knoop, Hans, Bredie, Sebastian J. H., Heijnen, Michael, Joosten, Leo A. B., Netea, Mihai G., Dinarello, Charles A., van der Meer, Jos W. M.
Publicado no Trials (2015)

Investigating neural mechanisms of change of cognitive behavioural therapy for chronic fatigue syndrome: a randomized controlled trial

Por van Der Schaaf, Marieke E, Schmits, Iris C, Roerink, Megan, Geurts, Dirk EM, Toni, Ivan, Roelofs, Karin, De Lange, Floris P, Nater, Urs M, van der Meer, Jos WM, Knoop, Hans
Publicado no BMC Psychiatry (2015)